B
NEO icon

Braidwell’s NeoGenomics NEO Stock Holding History

Braidwell’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$71.8M Sell
4,918,202
-699,200
-12% -$6.75M 2.65% 7
2026
Q1 		$41.7M Buy
5,617,402
+984,601
+21% +$10.4M 1.39% 28
2025
Q4 		$54.5M Buy
4,632,801
+2,861,655
+162% +$30.9M 1.74% 17
2025
Q3 		$13.7M Buy
+1,771,146
New +$12.4M 0.41% 60

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Braidwell's NEO Position: Q2 2026 in Review

Braidwell reduced its NeoGenomics (NEO) stake by 12% in Q2 2026, selling an estimated $6.75M and leaving 4,918,202 shares worth $71.8M. The position accounts for 2.65% of the portfolio, ranked #7.

Braidwell first reported a position in NEO in Q3 2025 and has held it in 4 quarters since. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Braidwell held 4,918,202 shares of NeoGenomics worth $71.8M as of Q2 2026.
  • Braidwell sold 699,200 NeoGenomics shares in Q2 2026, an estimated $6.75M.
  • NeoGenomics made up 2.65% of Braidwell's portfolio in Q2 2026, its #7 holding.
  • Braidwell first reported a position in NeoGenomics in Q3 2025 and has held it in 4 quarters since.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Braidwell's 13F filing for Q2 2026, filed 14 Aug 2026.